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        Viruses can initiate intracellular signal-
ing in part through Toll-like receptors 
(TLRs) and RLRs, which then trigger 
host immune responses. TLRs and RLRs 
function as pathogen recognition re-
ceptors (PRRs) that engage specifi  c 
pathogen-associated molecular pattern 
(PAMP) motifs, including viral RNA. 
TLR and RLR signaling activates IFN 
regulatory factors (IRFs) and nuclear 
factor     B (NF-    B), resulting in the ex-
pression of type I IFN and proinfl  am-
matory cytokines (  Fig. 1  ) (  1  ).   Type I 
IFNs then induce the expression of 
hundreds of IFN-stimulated genes that 
have direct antiviral actions and modu-
late adaptive immunity by enhancing 
natural killer cell function, activating 
immature dendritic cells (  2  –  4  ), and prim-
ing the survival and eff  ector functions 
of T and B cells (  5  –  9  ). 
  RIG-I is the prototypical member 
of the RLR family, which also includes 
melanoma differentiation  –  associated 
gene 5 (MDA5) and laboratory of ge-
netics and physiology 2 (LGP2). All 
RLRs have a C-terminal RNA helicase 
domain, whereas RIG-I and MDA5, but 
not LGP2, contain N-terminal tandem 
caspase activation recruitment domains 
(CARDs). Both RIG-I and LGP2 are 
regulated by a C-terminal repressor do-
main that is lacking in MDA5 (  10  ). Re-
cent studies have revealed that RIG-I 
and MDA5 detect diff  erent viruses (  11, 
12  ). The mechanism of PAMP recog-
nition by RIG-I has been characterized 
(  10, 13  –  16  ), but the MDA5 recognition 
mechanism was unknown. The study 
by Kato et al. (  17  ) on page   1601   of this 
issue reveals the nature of MDA5 lig-
ands and provides a basis for how MDA 
and RIG-I may diff  erentially recognize 
PAMPs. Here, we discuss these fi  nd-
ings in the context of recent advances 
made in the understanding of PAMP 
recognition and diff  erentiation by RLRs 
and TLRs. 
  TLRs and RLRs direct the front line 
of immunity 
  Innate immunity mediated through 
PAMP recognition by PRRs is the ear-
liest stage of immunity against viral in-
fection. The subsequent modulation of 
the adaptive immune response by PRR 
signaling has been studied using cells 
and mice defi  cient in specifi  c TLRs, 
RLRs, or their associated signaling adap-
tor proteins. Recent studies demon-
strated, for example, that the absence of 
specifi  c TLR pathways impairs adap-
tive immune responses against a variety 
of viruses (  18, 19  ). RLR signaling also 
seems to be critical for the outcome of 
Japanese encephalitis virus (JEV), ve-
sicular stomatitis virus (VSV), infl  uenza 
virus, and encephalomyocarditis virus 
(EMCV) infection (  11, 20, 21  ). In mice 
lacking RIG-I, MDA5, or the essential 
RLR adaptor molecule IFN promoter  –
  stimulator 1, JEV, VSV, infl  uenza vi-
rus, and ECMV were more virulent 
and replicated to higher levels than in 
wild-type mice, suggesting that RLR 
pathways are essential for controlling 
infection by these viruses (  11, 21, 22  ). 
Innate immune programs can also me-
diate antiviral immunity independent 
of adaptive immunity. For example, 
IRF3 target genes induced by RLR 
signaling directly control viral replica-
tion in infected tissues (  23, 24  ). Thus, 
depending on the nature of virus infec-
tion, TLRs and RLRs may work to-
gether or independently to mount an 
effi   cient immune response. 
  Discriminating between self- and viral 
RNAs 
  It is thought that the innate immune 
system protects the host from infection 
in a nonspecifi  c way. However, several 
studies have revealed that PAMP ligand 
recognition exhibits specifi  city.  This, 
along with diff  erences in cellular loca-
tion likely serve to distinguish self-RNA 
from nonself PAMP RNA, thus avoid-
ing type I IFN induction in response to 
components of host nucleic acids. For 
example, TLR7 recognizes a specifi  c 
motif within uridine-rich ribonucleo-
tide sequences (  25, 26  ), which are hy-
pothesized to be unique to RNA viruses. 
TLR9 recognizes DNA PAMP lig-
ands and triggers signaling through the 
MyD88 adaptor protein to induce type 
I IFN production (  27  ). The recogni-
tion of nonself DNA ligands by TLR9 
might also be sequence dependent, and 
some studies have implicated the sugar-
base-backbone sequence of PAMP DNA 
as a recognition factor (  28  –  30  ). 
  RLRs have been shown to recog-
nize viral RNA as nonself PAMPs. Un-
like TLRs, which are found either on the 
cell surface or within membrane-bound 
Retinoic acid  –  inducible gene (RIG)-I  –  like receptors (RLRs) are cytosolic RNA 
helicases that sense viral RNA and trigger signaling pathways that induce the 
production of type I interferons (IFNs) and proinfl  ammatory cytokines. RLRs 
recognize distinct and overlapping sets of viruses, but the mechanisms that 
dictate this specifi  city were unknown. A new study now provides evidence for 
size-based discrimination of double-stranded RNA (dsRNA) by RLRs and 
suggests how host cells recognize a variety of RNA viruses.
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studies, MDA5 appeared only to am-
plify type I IFN production as compared 
with RIG-I, whose actions were essen-
tial to initiate innate immunity (  12  ). 
  The study by Kato et al. (  17  ) in this 
issue describes a plausible mechanism 
of RNA ligand recognition by MDA5, 
providing new insights into the diff  er-
ential roles of RLRs. The study reveals 
that MDA5 binding to dsRNA does 
not depend on its 5     end modifi  cation, 
but rather on its length. dsRNAs with 
lengths of 2, 3, and 4 kb were shown 
to increasingly activate MDA5 signaling, 
whereas RIG-I recognized ssRNA and, 
to a lesser extent, short dsRNA motifs. 
cause their length, structure, 5     end 
modifi   cations, and interactions with 
ribonucleoproteins limit their recogni-
tion. Self-RNAs therefore do not typi-
cally trigger innate immune programs 
or type I IFN expression (  34  ). 
  The mechanism by which MDA5 
recognizes nonself RNA is less clear. 
MDA5 triggers innate immune signal-
ing in response to EMCV infection and 
synthetic dsRNA, such as poly I:C (  11, 
20  ). But ssRNA viruses such as Dengue 
virus and West Nile virus, as well as Reo-
virus, a dsRNA virus, have also been 
shown to trigger signaling partially via 
MDA5 (  12, 35  ). However, in these 
vesicles, RLRs are found in the cyto-
plasm where cellular RNA is also pre-
sent (  1  ). RIG-I preferentially recognizes 
single-stranded RNA (ssRNA) over 
dsRNA (  15, 31  ). ssRNAs containing a 
terminal 5     triphosphate (ppp), but not 
5    OH or a 5    -methylguanosine cap, 
bind to the RIG-I repressor domain and 
promote a conformational change that 
activates RIG-I signaling (  10, 13  –  16  ). 
RNA ligands of RIG-I are longer than 
23 nucleotides, have a linear structure, 
and contain a uridine- or adenosine-rich 
ribonucleotide sequence (  31  –  33  ). Host 
mRNA, tRNA, miRNA, snRNA, and 
rRNA are not ideal RIG-I ligands be-
    Figure 1.         Nucleic acid sensor molecules induce type I IFN and proinfl  ammatory cytokines.   PRRs occupy specifi  c intracellular sites that associate 
with the niche of different microbial pathogens. MDA5 and RIG-I both serve as cytoplasmic dsRNA receptors but distinguish their ligands in part by size; 
MDA5 binds to long dsRNA, whereas RIG-I binds short dsRNA. Among the TLRs, TLR3 recognizes dsRNA, TLR7/8 recognizes endosomal ssRNA, and TLR9 
binds to endosomal CpG DNA. PRR activation initiates downstream signaling that in turn activates transcription factors, including IRF-3, IRF-7, and 
NF-    B. The resulting expression of type I IFNs, proinfl  ammatory cytokines, and IFN-stimulated genes affect the innate immune response to confer pathogen 
resistance and enhance the adaptive immune response to infection.     JEM VOL. 205, July 7, 2008  1525
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that supports a RIG-I  –  dsRNA complex. 
However, the mechanism of length dis-
crimination of dsRNA PAMPs by these 
RLRs has not yet been revealed. 
  The third RLR family member, 
LGP2, has been defi  ned as a regulator of 
RIG-I signaling based on its suppression 
of RIG-I function when overexpressed 
in cultured cells (  10, 38, 39  ). However, 
recent studies imply that LGP2 may also 
function as either a positive or negative 
regulator of RLR signaling by forming a 
heterodimer with RIG-I or MDA5 when 
bound to RNA ligand (  40, 41  ). Such 
interactions between the RLRs may also 
broaden their PAMP recognition pro-
fi  les to accommodate other ligands, in-
cluding ssRNA or dsRNA of varied 
length and composition, or even DNA  –
  RNA duplexes. Structure and function 
analyses of RNA interactions with RLRs 
or heteromeric RLR complexes will fur-
ther defi  ne the molecular basis of self- 
versus nonself discrimination. 
  The RLR repressor domain determines 
ligand specifi  city 
  The RLRs are adenosine triphosphate 
(ATP) binding proteins that hydrolyze 
ATP as a result of binding RNA ligand 
(  15  ). However, the role of the ATPase 
activity in the function of RLRs is not 
fully understood. RLRs contain multi-
ple domains, including two domains 
known as the Walker A motif and the 
Walker B (also known as the DExD/
H-Box) motif, each located within the 
helicase domain (  42  ). Walker A and B 
motifs comprise an ATP binding region 
wherein specifi  c amino acid residues 
contact the     -phosphate of the nucleotide 
and mediate ATP hydrolysis upon sub-
strate binding (  43  –  45  ). Mutant RIG-I 
with an inactive Walker A motif retains 
ssRNA binding function but fails to 
trigger downstream signaling (  15, 46  ). 
Thus, ATP hydrolysis is not essential 
for PAMP binding but is required for 
downstream signaling. 
  Recent studies revealed that the 
RIG-I repressor domain, in addition to 
binding to the RIG-I CARDs, forms a 
complex with the helicase domain linker 
region that likely stabilizes RNA ligand 
binding (  10, 15, 16  ). Moreover, it seems 
that motifs in the RLR helicase domain 
dsRNA, whereas RIG-I binds to short 
dsRNA or 5    ppp uncapped ssRNA. 
When RIG-I binds to 5    ppp ssRNA, it 
changes conformation, which disrupts 
the inhibitory interaction between the 
RIG-I repressor domain and the CARDs. 
This alteration results in the initiation of 
downstream signaling by the CARDs and 
exposes a 17- or 30-kD trypsin-resistant 
fragment corresponding to the RIG-I 
repressor domain, thereby marking the 
activation of RIG-I (  10, 15, 16  ). How-
ever, poly I:C binding to RIG-I pro-
motes a distinct conformational change 
that results in a 66-kD trypsin-resistant 
fragment, indicating that PAMP-bound 
RIG-I undergoes a distinct conforma-
tional change depending on the nature of 
its ligand. Structural studies validate that 
RIG-I prefers ssRNA ligands, whereas 
dsRNA binds only ineffi   ciently to RIG-I, 
possibly due to constrains imposed by 
the location of basic residues within the 
RNA binding groove of its repressor 
domain. The charged residues are pro-
posed to anchor 5    ppp ssRNA within 
the pocket, which would be less amena-
ble to binding dsRNA ligands (  15, 16  ). 
These observations suggest that RIG-I 
may have two ways to distinguish diff  er-
ent RNA species: effi   cient recognition 
of 5    ppp ssRNA through its repressor 
domain (  10, 15, 16  ) and comparably 
ineffi   cient recognition and binding of 
dsRNA ( 10, 15 ). By extension, these con-
formational alterations of RIG-I might 
provide clues about how dsRNA lig-
ands interact with MDA5 to stimulate 
its activation. Thus, MDA5 might be-
come active upon binding long dsRNA 
through a ligand-induced conformation 
change that places its CARD into a sig-
naling-active conformation. This might 
involve dsRNA interactions with its he-
licase domain and C-terminal region in 
a fashion similar to the binding of poly I:
C to RIG-I. 
  Kato et al. and others have demon-
strated that although very short dsRNA 
(20  –  30 bp) fail to trigger RIG-I  –  depen-
dent signaling (  15, 17  ), longer dsRNAs 
ranging from     70 kb to 2 kb can at least 
weakly engage RIG-I. These data suggest 
that the length of dsRNAs may dictate the 
interaction with the RIG-I helicase do-
main and/or repressor domain in a manner 
These results help explain how reovirus 
can trigger both RIG-I and MDA5 sig-
naling. The genome of reovirus com-
prises at least 10 segments of dsRNA that 
vary in length, including long (3.9 kbp), 
medium (2.2 kbp), and short (1.2 kbp) 
RNA segments. Kato et al. show that 
RIG-I and MDA5 recognize the short 
and long dsRNA segments of the reovi-
rus genome, respectively. In the case of 
EMCV infection, the authors show that 
the viral genome forms long dsRNA via 
its antisense replication intermediate, and 
this dsRNA is recognized by MDA5 but 
not by RIG-I. On the other hand, VSV, 
which triggers RIG-I  –  dependent im-
munity, forms medium-length dsRNA 
replication intermediates that are not 
recognized by MDA5. Kato et al. pro-
pose a model for PAMP recognition by 
MDA5 in which only long dsRNA vi-
ral genomes or stable long duplex viral 
RNAs formed during virus replication 
serve as MDA ligands. This model might 
explain why MDA5 ignores self-dsRNA, 
which is typically not present as long du-
plex RNAs. 
  How do RIG-I and MDA5 recognize 
a broad spectrum of PAMPs? 
  The current observations advance our 
understanding of how MDA5 discrimi-
nates between potential RNA ligands, 
but several questions about recognition of 
RNA by RIG-I and MDA5 still remain. 
It is widely accepted that ssRNA viruses 
generate dsRNA during their replication 
process (  36, 37  ). However, only MDA5 
recognizes EMCV (8 kb), whereas RIG-I 
recognizes other viruses with lengthy 
RNA genomes, such as VSV (11 kb), 
JEV (11 kb), and hepatitis C virus (9.6 
kb). MDA5  ’  s failure to recognize these 
latter viruses may be due to their inability 
to form long or perhaps stable dsRNA. It 
is also possible that recognition by MDA5 
depends on specifi  c compartmentaliza-
tion of the PAMP RNA with MDA5, as 
diff  erences in the subcellular site of vi-
ral genome replication may infl  uence 
the PAMP  –  MDA5 interaction. 
  The mechanism by which MDA5 
discriminates between PAMP ligands 
in terms of their length is also unclear. 
Kato et al. demonstrate that MDA5 binds 
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could also be involved in RNA sub-
strate binding according to structure and 
function studies of other DExD/H-Box 
RNA helicases (  42  ). Such studies indi-
cate that the RNA binding sites and the 
Walker A and B motifs mediate specifi  c 
interactions (  47  ). These observations pre-
sent a model in which a repressor do-
main  –  helicase domain internal complex 
forms an RNA binding pocket whose 
association with PAMP RNA may serve 
to initiate the ATPase activity of RIG-I, 
which then triggers a conformation 
change that allows innate immune sig-
naling. The repressor  –  helicase domain 
interaction of RLRs may thus be the 
key determinant of PAMP discrimina-
tion by RIG-I and MDA5 (  15, 17  ). It 
also seems that RIG-I ATPase activity is 
involved in the unwinding of dsRNA 
(  15  ). The importance of this activity for 
innate immune function is unclear, but 
it might support RIG-I interaction with 
dsRNA ligands by catalyzing their con-
version to ssRNAs. 
  Future perspectives 
  The breadth of PRRs expressed in dif-
ferent cells and tissues and their distinct 
intracellular distribution provide the 
means for PAMP detection and immune 
activation against a variety of microbial 
pathogens at the local site of infection or 
in the   “  microbial niche.  ”   These include 
the membrane-associated cytosolic repli-
cation sites of RNA viruses, extracellular 
sites of microbe interaction, and endo-
somal sites of microbial traffi   cking and 
metabolism (  Fig. 1  ). The recent iden-
tifi  cation of the DAI (DLM-1/ZBP1) 
protein as a cytoplasmic sensor of micro-
bial DNA (  48  ) suggests the existence of 
other PRRs that detect cytosolic PAMP 
DNA. It is reasonable to speculate that, 
similar to TLRs and RLRs, the cyto-
plasmic DNA sensor molecules also ex-
hibit ligand specifi  city to cover a variety 
of DNA PAMPs in association with 
their specifi  c microbial niche, thus pro-
viding a further basis for self- versus 
nonself discrimination. Understanding 
the processes of PAMP ligand recog-
nition within each microbial niche will 
provide a foundation for the design 
of appropriate vaccines, adjuvants, and 
immunotherapies. JEM VOL. 205, July 7, 2008  1527
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